Learn, Analyse & Invest
only with
only with
+91
Download Orca
Lasa Supergenerics Ltd.
Lasa Supergenerics
₹ 0.00
0.00 (0.00)%
NSE
BSE
Healthcare
Small-cap - With a market cap of ₹40.03 Cr.
| EX-Date | Purpose |
|---|---|
| 25 05 2021 | Audited Results |
| 31 05 2021 | Audited Results (Revised) |
| 14 08 2021 | A.G.M. & Quarterly Results |
| 14 11 2021 | Quarterly Results (Revised) |
| 15 11 2021 | Quarterly Results |
| 07 02 2022 | Quarterly Results |
| 11 04 2022 | Final Dividend & Audited Results |
| 08 08 2022 | Quarterly Results |
| 14 11 2022 | Quarterly Results |
| 14 02 2023 | Quarterly Results |
| 29 05 2023 | Quarterly Results |
| 07 06 2023 | Audited Results (Revised) & Quarterly Results |
| 14 08 2023 | Quarterly Results |
| 10 11 2023 | Quarterly Results |
| 13 02 2024 | Quarterly Results |
| 14 11 2024 | Quarterly Results |
| 24 01 2025 | Issue Of Warrants |
| 24 01 2025 | Postponed Board Meeting (Cancelled) |
| 28 01 2025 | inter alia; 1. To consider, approve, finalize the issue of warrants and price of warrants convertible into equity shares / or equity shares to be issued on preferential basis in accordance with the provisions of SEBI (Issue of Capital and Disclosure Requirements) Regulations, 2018 (SEBI ICDR Regulations). 2. To consider, approve, finalize, the proposal of fund raising by way of equity shares through rights issue in accordance with the provisions of SEBI (Issue of Capital and Disclosure Requirements) Regulations, 2018 (SEBI ICDR Regulations) as permitted under applicable law, subject to such regulatory/statutory approvals as may be required. 3. Any other matter with the permission of chair. |
| 13 02 2025 | Quarterly Results |
| 26 05 2025 | Quarterly Results & Audited Results |
| 13 08 2025 | Quarterly Results |
| 14 11 2025 | Quarterly Results |
| 13 02 2026 | Quarterly Results |
News
